Aging reshapes the duodenal microenvironment in two interconnected ways: first, it expands a dysfunctional intestinal stem cell (ISC) pool that fails to sustain proper niche signals; second, it shifts the microbiota toward Akkermansia muciniphila‑dominant communities that suppress Wnt/β‑catenin signaling essential for ISC self‑renewal [1][2]. Because duodenal K‑cells turnover every < 5 days and depend entirely on a vigorous ISC niche for replacement [3], we hypothesize that the age‑induced Wnt deficit indirectly compromises K‑cell nutrient‑sensing machinery, leading to blunted GLP‑1 and GIP secretion despite normal luminal nutrient levels. Moreover, we propose that the microbiota shift reduces luminal butyrate, a histone deacetylase (HDAC) inhibitor, causing hyperacetylation and nuclear retention of FoxO1. FoxO1 then represses transcription of key nutrient transporters and receptors—SGLT1 for glucose uptake and GPR40/120 for fatty‑acid sensing—in K‑cells, directly linking microbial metabolism to enteroendocrine function.

This hypothesis yields several testable predictions. (1) In 24‑month‑old mice, duodenal K‑cells isolated by fluorescence‑activated cell sorting will show significantly lower Sglt1, Gpr40, and Gpr120 mRNA and protein levels compared with 3‑month‑old controls, while FoxO1 acetylation and nuclear localization will be elevated. (2) Oral glucose or lipid tolerance tests will reveal attenuated GLP‑1 and GIP secretion in old mice, correlating with the reduced transporter/receptor expression. (3) Faecal microbiota transplantation (FMT) from young donors into aged recipients will restore Wnt target gene expression (e.g., Axin2, Lgr5) in ISCs, increase luminal butyrate concentrations, normalize FoxO1 acetylation, and rescue SGLT1/GPR40/120 levels in K‑cells, thereby restoring incretin responses to youthful magnitudes. (4) Direct supplementation of Wnt3a to aged intestinal organoids will rescue ISC proliferation and organoid formation [4] but will only partially restore K‑cell transporter expression unless supplemented with sodium butyrate, indicating that Wnt rescue is necessary but not sufficient for full nutriento‑sensing recovery. (5) Pharmacological inhibition of FoxO1 (e.g., with AS1842856) in aged mice will increase Sglt1 and Gpr40 transcription and improve GLP‑1/GIP secretion even without microbiota alteration, confirming the causal role of the FoxO1 axis.

These experiments are feasible with existing tools: lineage‑tracing reporters for K‑cells, qPCR/Western blot for transporter and FoxO1 readouts, ELISA for incretin hormones, and metabolomics for luminal butyrate. Confirmation would reframe age‑related metabolic decline as a downstream consequence of microbiota‑Wnt‑FoxO1 signaling dysregulation in the duodenal epithelium, suggesting combinatorial strategies—microbiota restoration, Wnt activation, and butyrate or FoxO1 modulation—to reinstate incretin competence and improve metabolic health in aging.